Skip to main content
AI Market Watch
Loading...

JotPsych

Category: AI in Healthcare

JotPsych is an AI-powered medical documentation tool and scribe for behavioral health professionals. JotPsych was founded in 2023. The company is led by Nathan Peereboom. Based in Brooklyn, New York, USA. Team size: 12. Total funding raised: Approximately $5.3 million. Latest round: Seed. Key investors include Base10 Partners.

Founded
2023
Headquarters
Brooklyn, New York, USA
Team size
12
Total funding
Approximately $5.3 million

Value proposition

To reduce the administrative burden on behavioral health clinicians by automating the creation of clinical notes, thereby saving them up to 90% of their charting time and allowing for greater focus on patient care.

Products and solutions

AI-powered Scribe: A tool that listens to patient interactions and generates complete, HIPAA-friendly, and medically-accurate clinical notes., JotAudit: An audit-intelligence platform that standardizes documentation, workflows, clinician training, and reduces audit risk (launched Jan 2026)., Agentic EHR platform: Expanding to include scheduling, billing/RCM, e-prescribing, credentialing, and patient messaging.

Unique value

JotPsych is unique due to its specialized focus on the behavioral health sector, with an AI model tailored to understand and document the specific language and nuances of mental health consultations. Unlike general medical scribes, it is built to handle the complexities of psychiatric and therapeutic documentation.

Target customer

Behavioral health clinicians, including psychiatrists, psychologists, therapists, and psychiatric mental health nurse practitioners (PMHNPs).

Industries served

Healthcare, Behavioral Health

Technology advantage

The key technological advantage is its AI-powered scribe that automates clinical note-generation, ensuring HIPAA compliance and medical accuracy. The business advantage comes from addressing a major pain point for a specific, underserved niche within healthcare, and being backed by a significant $5M seed investment from a reputable venture capital firm, Base10 Partners.

How they differentiate

JotPsych differentiates by focusing exclusively on behavioral health, aiming to provide a more tailored and comprehensive solution than general medical AI scribes. It plans to evolve from an AI scribe into a fully agentic EHR that handles all administrative layers, not just clinical notes.

Main competitors

Scribe Health, Freed, Nabla

Key partnerships

Base10 Partners (Lead Investor), Microsoft for Startups (Partner)

Notable customers

Over 10,000 behavioral health practices (as of early 2026), Viking Psychiatry, Every Rose Psychiatry, Idaho TMS, Renew Wellness, Mugen Psychiatry, Selah Health, Vera French

Major milestones

Successfully closed a $5 million seed funding round led by Base10 Partners (July 2025)., Building the first fully agentic EHR specifically for the behavioral health industry., Grew 1300%+ in 2024., Processed over 1,000,000 patient encounters., Launched JotAudit, an AI-driven audit-intelligence platform (January 2026)., Expanded to serve over 10,000 behavioral health practices.

Growth metrics

1300%+ growth in 2024; over 1,000,000 patient encounters processed; over 10,000 behavioral health practices using the platform.

Market positioning

JotPsych is positioned as a specialized AI-powered clinical documentation tool for behavioral health professionals, including psychiatrists, therapists, and counselors. It targets clinicians who are looking to significantly reduce time spent on administrative tasks and paperwork.

Geographic focus

JotPsych is based in Brooklyn, New York, and its primary market focus is the United States.

Patents and IP

Information on patents or specific IP is not publicly available.

About Nathan Peereboom

Former Private Equity Associate at Silver Lake and Investment Banking Analyst at Guggenheim Partners. Co-founded JotPsych to address administrative burdens in behavioral health.

More AI in Healthcare companies

Official website:

JotPsych - AI Startup Profile | AI Market Watch